Casting and extrusion |
Biomaterial inks (carbopol gel) |
0.7% w/v carbopol |
Synthetic material |
Polydimethylsiloxane (PDMS) |
PDMS mixed with its curing agent at a 10:1 ratio |
[48] |
Casting and inkjet and FDM |
Biomaterial inks (polycaprolactone particle) |
Polycaprolactone particle with the molecular weight of 80,000 g/mol |
Synthetic material |
GelMA + gelatin |
10% w/v GelMA + gelatin of a certain concentration |
[136] |
Casting and inkjet |
Biomaterial inks (polycaprolactone) |
Polycaprolactone with the molecular weight of 80,000 g/mol |
Synthetic material |
GelMA |
10% w/v GelMA |
[99] |
Casting and extrusion and stereolithography (SLA) |
Biomaterial inks (gelatin for extrusion + E-Shell 300 clear resin for SLA) |
15% w/w gelatin + E-Shell 300 clear resin with a certain concentration |
Natural material (gelatin); synthetic material (E-Shell 300 clear resin) |
Extracellular matrix |
Extracellular matrix with a certain composition and concentration |
[137] |
Electrospinning and extrusion |
Biomaterial inks (Polylactic acid) and bioinks excluding cells (alginate + gelatin) |
Polylactic acid with the diameter of 1.75 mm; 2% w/v alginate (w/v) + 6% w/v gelatin |
Synthetic material (Polylactic acid); compositive material (alginate + gelatin) |
Polycaprolactone |
Polycaprolactone with the molecular weight of 80,000 g/mol |
[49] |
Electrospinning and extrusion |
Biomaterial inks (polyvinyl alcohol + collagen) |
20% wt. polyvinyl alcohol + 4% wt. collagen |
Compositive material |
Alginate + polyethylene oxide |
2% wt. alginate and 3% wt. polyethylene oxide |
[142] |
Electrospinning and inkjet |
Biomaterial inks (hydroxyapatite) |
6% wt. hydroxyapatite |
Synthetic material |
Polycaprolactone |
17% w/v polycaprolactone |
[144] |
Electrospinning and inkjet |
Biomaterial inks (polycaprolactone) |
6% w/v polycaprolactone |
Synthetic material |
Polycaprolactone + polyethylene glycol |
6% w/v polycaprolactone + 10% w/v polyethylene glycol |
[143] |
Electrospinning and inkjet |
Biomaterial inks (polycaprolactone) |
15% wt. polycaprolactone |
Synthetic material |
Polycaprolactone |
25% wt. polycaprolactone |
[62] |
Electrospinning and stereolithography (SLA) |
Biomaterial inks (polyethylene glycol + polyethylene (glycol) diacrylate) |
40% wt. polyethylene glycol + 60% wt. polyethylene (glycol) diacrylate |
Synthetic material |
Polycaprolactone + gelatin |
15% w/v polycaprolactone + 20% w/v gelatin |
[145] |
Lego-like construction and extrusion and FDM and casting |
Bioinks excluding cells (alginate hydrogel for extrusion); biomaterial inks (maltitol for FDM) |
3% w/v sodium alginate; fused maltitol |
Natural material (sodium alginate); synthetic material (maltitol) |
PDMS |
PDMS prepared by mixing the base and curing agents at 10:1 (w/w) ratio |
[151] |
Lego-like construction and stereolithography (DLP) |
Biomaterial inks (GelMA + ceramic) |
7-9% w/v GelMA + ceramic with high density (97%) |
Compositive material |
N/A |
N/A |
[149] |
Lego-like construction and stereolithography (DLP) and casting |
Biomaterial inks (a clear resin consists of triethylene glycol diacrylate and isobornyl methacrylate) |
A resin with a component concentration described in the product information |
Compositive material |
Gold and PDMS |
20 nm thick gold + PDMS with a 10:1 ratio of base to curing agent |
[152] |
Lego-like construction and stereolithography (SLA) |
Biomaterial inks (poly(ethylene glycol) diacrylate + poly(acrylic acid)) |
10% w/v poly(ethylene glycol) diacrylate + 5% w/v poly(acrylic acid) |
Compositive material |
N/A |
N/A |
[150] |